Treatment of Anorexia Nervosa in Children and Adolescents: An Integrated Family Based and Metacognitive Approach
FBT-MCT
1 other identifier
interventional
48
1 country
1
Brief Summary
The goal of this study is to evaluate the treatment effects of an integrated treatment called Family-based and Metacognitive therapy for patients with Anorexia Nervosa. In addition, we will evaluate if an active follow-up of the patients will reduce the number of relapses, which is common during the 1 year after discharge. Fifty patients aged 12-18 years old and their parents will be invited to participate in this study and all will receive the same treatment but be randomly allocated to different follow-up conditions. The active follow-up includes 3 sessions of Metacognitive therapy and the passive follow-up includes ordinary follow-up, with no booster sessions. The patients will be assessed at baseline, pre-treatment, post-treatment, and at 6 and 12 months follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2023
CompletedStudy Start
First participant enrolled
November 1, 2023
CompletedFirst Posted
Study publicly available on registry
November 18, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2026
ExpectedJune 22, 2025
June 1, 2025
2.1 years
August 24, 2023
June 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Body Mass Index
Body mass index
18 months
Study Arms (2)
Active follow-up
ACTIVE COMPARATORThe patients will recieve 3 sessions of MCT
Passive follow-up
ACTIVE COMPARATORThe group receives no sessions during follow-up
Interventions
Family based therapy and Metacognitive therapy
Eligibility Criteria
You may qualify if:
- Primary diagnosis of F 50.0 and F 50.1
You may not qualify if:
- Psychotic symptoms
- Severe somatic illness
- Mental retardation or developmental disorder
- Bipolar disorder
- Extreme self-mutilation or acute suicidal risks
- Does not speak or understand Norwegian
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Norwegian University of Science and Technologylead
- St. Olavs Hospitalcollaborator
Study Sites (1)
St.Olavs hospital HF
Trondheim, Trøndelag, 7006, Norway
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2023
First Posted
November 18, 2023
Study Start
November 1, 2023
Primary Completion
December 1, 2025
Study Completion (Estimated)
December 1, 2026
Last Updated
June 22, 2025
Record last verified: 2025-06